Siemens Healthineers AG (MIL:1SHL) Short Interest

View and export this data going back to 2023. Start your Free Trial

What is Siemens Healthineers AG Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Siemens Healthineers AG's Short Interest

For the Medical Devices subindustry, Siemens Healthineers AG's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Siemens Healthineers AG's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's Short Interest distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's Short Interest falls into.

Siemens Healthineers AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (MIL:1SHL) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

SEMHF:USA SMMNY:USA SHLd:UK 0PMJ:UK SHL:Germany SHL:Austria

Address

Siemensstr. 3, Forchheim, BY, DEU, 91301

Website

https://www.siemens-healthineers.com

Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.

Siemens Healthineers AG Headlines

No Headlines